L. Earnest-Silveira

909 total citations
19 papers, 719 citations indexed

About

L. Earnest-Silveira is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. Earnest-Silveira has authored 19 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 16 papers in Epidemiology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. Earnest-Silveira's work include Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (15 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). L. Earnest-Silveira is often cited by papers focused on Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (15 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). L. Earnest-Silveira collaborates with scholars based in Australia, Germany and India. L. Earnest-Silveira's co-authors include Joseph Torresi, David C. Jackson, Dale Christiansen, Stephen Locarnini, Janet Fyfe, C.–Thomas Bock, Eric J. Gowans, Georgia Deliyannis, Kristy L. Edgtton and Hui Zhuang and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

L. Earnest-Silveira

19 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Earnest-Silveira Australia 14 540 515 122 116 79 19 719
Marie–Sophie Hiet Germany 7 430 0.8× 532 1.0× 159 1.3× 66 0.6× 84 1.1× 8 697
Caroline Scholtès France 20 867 1.6× 915 1.8× 147 1.2× 308 2.7× 50 0.6× 46 1.2k
Danni Colledge Australia 21 1.1k 2.1× 1.0k 1.9× 136 1.1× 375 3.2× 117 1.5× 33 1.3k
Abdul Ghafoor Khan United States 12 271 0.5× 273 0.5× 315 2.6× 104 0.9× 194 2.5× 15 748
James H. McLinden United States 19 299 0.6× 364 0.7× 173 1.4× 170 1.5× 127 1.6× 39 781
Auda A. Eltahla Australia 15 199 0.4× 240 0.5× 239 2.0× 223 1.9× 247 3.1× 25 752
T Andoh Japan 3 568 1.1× 797 1.5× 180 1.5× 87 0.8× 39 0.5× 7 871
Florence Dô Canada 9 219 0.4× 120 0.2× 108 0.9× 159 1.4× 70 0.9× 12 448
V. Bichko United States 15 777 1.4× 723 1.4× 193 1.6× 196 1.7× 155 2.0× 35 1.0k
Charlotte Hedskog United States 17 941 1.7× 1.0k 2.0× 194 1.6× 457 3.9× 40 0.5× 41 1.3k

Countries citing papers authored by L. Earnest-Silveira

Since Specialization
Citations

This map shows the geographic impact of L. Earnest-Silveira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Earnest-Silveira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Earnest-Silveira more than expected).

Fields of papers citing papers by L. Earnest-Silveira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Earnest-Silveira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Earnest-Silveira. The network helps show where L. Earnest-Silveira may publish in the future.

Co-authorship network of co-authors of L. Earnest-Silveira

This figure shows the co-authorship network connecting the top 25 collaborators of L. Earnest-Silveira. A scholar is included among the top collaborators of L. Earnest-Silveira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Earnest-Silveira. L. Earnest-Silveira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Masavuli, Makutiro G., Danushka K. Wijesundara, Alexander P. Underwood, et al.. (2019). A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice. Frontiers in Immunology. 10. 1145–1145. 30 indexed citations
2.
Torresi, Joseph, et al.. (2019). HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models. BMC Cancer. 19(1). 707–707. 72 indexed citations
3.
Christiansen, Dale, L. Earnest-Silveira, Branka Grubor‐Bauk, et al.. (2019). Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery. Scientific Reports. 9(1). 9251–9251. 48 indexed citations
4.
Torresi, Joseph, et al.. (2019). Probing and pressing surfaces of hepatitis C virus-like particles. Journal of Colloid and Interface Science. 545. 259–268. 20 indexed citations
5.
Christiansen, Dale, L. Earnest-Silveira, Brendon Y. Chua, et al.. (2018). Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists. Viral Immunology. 31(4). 338–343. 9 indexed citations
6.
Christiansen, Dale, L. Earnest-Silveira, Brendon Y. Chua, et al.. (2018). Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine. Scientific Reports. 8(1). 6483–6483. 33 indexed citations
7.
Earnest-Silveira, L., Dale Christiansen, Susann Herrmann, et al.. (2016). Large scale production of a mammalian cell derived quadrivalent hepatitis C virus like particle vaccine. Journal of Virological Methods. 236. 87–92. 18 indexed citations
8.
Earnest-Silveira, L., Brendon Y. Chua, Rey Chin, et al.. (2016). Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line. Journal of General Virology. 97(8). 1865–1876. 25 indexed citations
9.
Chin, Ruth, L. Earnest-Silveira, Peter Angus, et al.. (2014). Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosis. Journal of General Virology. 95(10). 2204–2215. 23 indexed citations
10.
Chua, Brendon Y., Douglas Johnson, Amabel C. L. Tan, et al.. (2012). Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses. PLoS ONE. 7(10). e47492–e47492. 44 indexed citations
11.
Chin, Ruth, Ueli Nachbur, L. Earnest-Silveira, et al.. (2009). Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus. Virus Research. 147(1). 7–16. 9 indexed citations
12.
Chin, Ruth, L. Earnest-Silveira, Hanswalter Zentgraf, et al.. (2008). Failure of Lamivudine to Reverse Hepatitis B Virus-Associated Changes in ERK, Akt and Cell Cycle Regulatory Proteins. Antiviral Therapy. 13(2). 221–230. 7 indexed citations
13.
Yotnda, Patricia, Campbell Aitken, L. Earnest-Silveira, et al.. (2008). Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response. Clinical Immunology. 128(3). 329–339. 16 indexed citations
14.
Chin, Russell L., L. Earnest-Silveira, Sergej Franz, et al.. (2008). 632 RECOMBINANT HCV VIRUS LIKE PARTICLES TO INDUCE HUMORAL AND NEUTRALISING ANTIBODY RESPONSES TO HCV. Journal of Hepatology. 48. S235–S235. 1 indexed citations
15.
Torresi, Joseph, Owen Stock, Lara Grollo, et al.. (2007). A self‐adjuvanting multiepitope immunogen that induces a broadly cross‐reactive antibody to hepatitis C virus†. Hepatology. 45(4). 911–920. 23 indexed citations
16.
Chin, Ruth, L. Earnest-Silveira, Hanswalter Zentgraf, et al.. (2007). Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: Factors contributing to hepatocarcinogenesis. Journal of Hepatology. 47(3). 325–337. 57 indexed citations
17.
18.
Torresi, Joseph, L. Earnest-Silveira, Georgia Deliyannis, et al.. (2002). Reduced Antigenicity of the Hepatitis B Virus HBsAg Protein Arising as a Consequence of Sequence Changes in the Overlapping Polymerase Gene That Are Selected by Lamivudine Therapy. Virology. 293(2). 305–313. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026